Tang Kevin: insider trades.
Tang Kevin reported 23 non-derivative transactions on 9 SEC ownership filings in Q3 2026: 22 open-market purchases ($2.3M) and 1 sale ($54K), across 2 companies.
- Transactions
- 23
- Purchases (P)
- 22
- Sales (S)
- 1
- Companies
- 2
- Name as filed
- TANG KEVIN
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Boundless Bio, Inc. (BOLD) | TenPercentOwner | 17 |
| Fulcrum Therapeutics, Inc. (FULC) | TenPercentOwner | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-26 | Boundless Bio, Inc. | S | 18,300 | $2.97 | 2,840,635 | Form 4 |
| 2026-07-21 | Boundless Bio, Inc. | P | 2,975 | $2.44 | 2,858,935 | Form 4 |
| 2026-07-20 | Boundless Bio, Inc. | P | 1,623 | $2.44 | 2,855,960 | Form 4 |
| 2026-07-17 | Boundless Bio, Inc. | P | 265 | $2.44 | 2,854,337 | Form 4 |
| 2026-07-17 | Fulcrum Therapeutics, Inc. | P | 50,945 | $3.52 | 7,080,945 | Form 4 |
| 2026-07-16 | Fulcrum Therapeutics, Inc. | P | 116,671 | $3.56 | 7,030,000 | Form 4 |
| 2026-07-16 | Boundless Bio, Inc. | P | 18,491 | $2.44 | 2,854,072 | Form 4 |
| 2026-07-15 | Boundless Bio, Inc. | P | 1,600 | $2.44 | 2,835,581 | Form 4 |
| 2026-07-15 | Fulcrum Therapeutics, Inc. | P | 107,377 | $3.56 | 6,913,329 | Form 4 |
| 2026-07-14 | Boundless Bio, Inc. | P | 43,878 | $2.43 | 2,833,981 | Form 4 |
| 2026-07-14 | Fulcrum Therapeutics, Inc. | P | 75,952 | $3.58 | 6,805,952 | Form 4 |
| 2026-07-14 | Fulcrum Therapeutics, Inc. | P | 53,651 | $3.56 | 6,730,000 | Form 4 |
| 2026-07-13 | Fulcrum Therapeutics, Inc. | P | 12,966 | $3.54 | 6,676,349 | Form 4 |
| 2026-07-13 | Boundless Bio, Inc. | P | 48,211 | $2.42 | 2,790,103 | Form 4 |
| 2026-07-10 | Boundless Bio, Inc. | P | 43,367 | $2.43 | 2,741,892 | Form 4 |
| 2026-07-09 | Boundless Bio, Inc. | P | 7 | $2.48 | 2,698,525 | Form 4 |
| 2026-07-08 | Boundless Bio, Inc. | P | 14,338 | $2.46 | 2,698,518 | Form 4 |
| 2026-07-07 | Boundless Bio, Inc. | P | 15,810 | $2.48 | 2,684,180 | Form 4 |
| 2026-07-06 | Boundless Bio, Inc. | P | 27,062 | $2.49 | 2,668,370 | Form 4 |
| 2026-07-02 | Boundless Bio, Inc. | P | 9,821 | $2.49 | 2,641,308 | Form 4 |
| 2026-07-01 | Boundless Bio, Inc. | P | 71,612 | $2.49 | 2,631,487 | Form 4 |
| 2026-06-30 | Boundless Bio, Inc. | P | 25,930 | $2.54 | 2,559,775 | Form 4 |
| 2026-06-30 | Boundless Bio, Inc. | P | 100 | $2.5 | 2,559,875 | Form 4 |
Questions
What stock did Tang Kevin buy or sell?
Tang Kevin reported 23 non-derivative transactions on 9 SEC ownership filings in Q3 2026: 22 open-market purchases ($2.3M) and 1 sale ($54K), across 2 companies.
Is Tang Kevin the same person as other filers with this name?
This page covers SEC CIK 1178579 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/tang-kevin-1178579.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.